The majority of patients across all groups those currently on a GLP-1, thinking of it, or who used to take one said "yes." Among those who used to take a GLP-1, 42% said they gained "some" weight back after stopping treatment
For the primary composite outcome and secondary hierarchical outcomes, the threshold for two-sided statistical significance was set to 0.0322 (one-sided level 0.00161) using Lan-DeMets alpha spending function, which allows to adjust significance levels as data were reviewed for the interim analysis, reducing the chance of false positive results
Quarter of your plate: complex carbohydrates
After 17 days of treatment, liraglutide reduced activation in the inferior parietal cortex in response to highly desirable versus less desirable food images (Farr et al., 2016), but after 5 weeks of treatment, no significant differences emerged in the main analysis (Farr et al., 2019)
FullSwitch SUGGESTED USE: As a dietary supplement, adults take four (4) capsules daily with a meal and 8 fl oz of water, or as directed by a healthcare professional
Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis
